共 50 条
Monitoring of amoxicilline and ceftazidime in the microdialysate of diabetic foot and serum by capillary electrophoresis with contactless conductivity detection
被引:16
|作者:
Tuma, Petr
[1
]
Jacek, Martin
[1
]
Sommerova, Blanka
[1
]
Dlouhy, Pavel
[1
]
Jarosikova, Radka
[2
]
Husakova, Jitka
[2
]
Woskova, Veronika
[2
]
Fejfarova, Vladimira
[2
]
机构:
[1] Charles Univ Prague, Fac Med 3, Dept Hyg, Ruska 87, Prague 10000 10, Czech Republic
[2] Inst Clin & Expt Med, Diabet Ctr, Prague 4, Czech Republic
关键词:
antibiotic;
CE;
contactless conductivity detection;
diabetic foot;
microdialysis;
BETA-LACTAM ANTIBIOTICS;
HUMAN PLASMA;
SENSITIVE DETERMINATION;
CEREBROSPINAL-FLUID;
RAPID-DETERMINATION;
CLAVULANIC ACID;
HUMAN BLOOD;
HPLC-DAD;
CHROMATOGRAPHY;
TOBRAMYCIN;
D O I:
10.1002/elps.202100366
中图分类号:
Q5 [生物化学];
学科分类号:
071010 ;
081704 ;
摘要:
Determination of the broad-spectrum antibiotics amoxicilline (AMX) and ceftazidime (CTZ) in blood serum and microdialysates of the subcutaneous tissue of the lower limbs is performed using CE with contactless conductivity detection ((CD)-D-4). Baseline separation of AMX is achieved in 0.5 M acetic acid as the background electrolyte and separation of CTZ in 3.2 M acetic acid with addition of 13% v/v methanol. The CE-(CD)-D-4 determination is performed in a 25 mu m capillary with suppression of the EOF using INST-coating on an effective length of 18 cm and the attained migration time is 4.2 min for AMX and 4.4 min for CTZ. The analysis was performed using 20 mu l of serum and 15 mu l of microdialysate, treated by the addition of acetonitrile in a ratio of 1/3 v/v and the sample is injected into the capillary using the large volume sample stacking technique. The LOQ attained in the microdialysate is 148 ng/ml for AMX and 339 ng/ml for CTZ, and in serum 143 ng/ml for AMX and 318 ng/ml for CTZ. The CE-(CD)-D-4 method is employed for monitoring the passage of AMX and CTZ from the blood circulatory system into the subcutaneous tissue at the sites of diabetic ulceration in patients suffering from diabetic foot syndrome and also for measuring the pharmacokinetics following intravenous application of bolus antibiotic doses.
引用
收藏
页码:1129 / 1139
页数:11
相关论文